A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way ...
MedPage Today on MSN
mRNA melanoma vaccine cuts risk of recurrence or death, leaked trial data show
"We may be witnessing the beginning of an entirely new way of treating cancer," expert say ...
A personalised mRNA cancer vaccine jointly developed by Moderna Inc (NASDAQ:MRNA, XETRA:0QF) and MSD (Unlisted (UK):MSD) has reduced the risk of melanoma recurrence or death by 42% in a landmark Phase ...
A New Zealand agency has invested in a US startup developing a vaccine to reduce livestock methane emissions, but the jab does not use mRNA, contrary to conspiratorial posts online reviving Covid-era ...
Severe sunburn increases the risk of developing melanoma, the most serious type of skin cancer. Credit: Olga Pankova/Getty. A ...
Rutgers tested a needle-free mRNA vaccine in mice and found aluminum phosphate plus CpG DNA cut lung RNA after SARS-CoV-2 ...
Rutgers University researchers and Japanese institutions found a needle-free mRNA vaccine protected mice against SARS-CoV-2 ...
How does the cell convert DNA into working proteins? The process of translation can be seen as the decoding of instructions for making proteins, involving mRNA in transcription as well as tRNA. But ...
Researchers engineered hybrid strontium sulfite nanoparticle-modified lipid nanoparticles to deliver p53 mRNA, producing ...
The collaboration will combine Sanofi’s mRNA drug candidates with ScionxBio’s AI-driven TERA platform to develop ...
Oxford biotech secures $47 million to scale cell-based mRNA manufacturing, with an eye on therapies that require repeated ...
Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "North America DNA Plasmid Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis" has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results